United Therapeutics reported $5.71 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 5.71 7.24 7.16 Nov/04
FY2026Q2 Jun/2026 7.27 7.17 6.41 Aug/05
FY2026Q1 Mar/2026 5.82 6.94 6.63 May/06
FY2025Q4 Dec/2025 7.70 7.07 6.19 Feb/25
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29




Eps Change Date
Amarin USD 0.14 0.06 Dec/2025
Ardelyx USD -0.07 0.08 Jun/2026
Baxter International USD 0.58 0.02 Sep/2026
Bayer EUR 0.31 0.64 Sep/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Insmed USD -0.46 0.4 Sep/2026
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Moderna USD 0.38 2.35 Sep/2026
Omeros USD -1.12 0.37 Jun/2024
Pfizer USD 0.87 0.1 Sep/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Teva Pharmaceutical Industries USD 0.79 0.73 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026